TD Asset Management Inc Has $9.55 Million Holdings in Revvity Inc. $RVTY

TD Asset Management Inc cut its position in Revvity Inc. (NYSE:RVTY) by 13.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,690 shares of the company’s stock after selling 15,162 shares during the period. TD Asset Management Inc owned 0.08% of Revvity worth $9,545,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in RVTY. Farther Finance Advisors LLC boosted its position in Revvity by 21.2% in the first quarter. Farther Finance Advisors LLC now owns 796 shares of the company’s stock valued at $83,000 after buying an additional 139 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Revvity by 42.9% during the first quarter. GAMMA Investing LLC now owns 2,713 shares of the company’s stock worth $287,000 after purchasing an additional 815 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Revvity by 3.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 5,139 shares of the company’s stock worth $544,000 after purchasing an additional 187 shares in the last quarter. Ritholtz Wealth Management acquired a new position in shares of Revvity during the first quarter worth approximately $210,000. Finally, Janney Montgomery Scott LLC raised its stake in shares of Revvity by 39.4% during the first quarter. Janney Montgomery Scott LLC now owns 10,998 shares of the company’s stock worth $1,164,000 after buying an additional 3,107 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Down 0.4%

Shares of NYSE:RVTY opened at $93.60 on Monday. Revvity Inc. has a 52 week low of $81.36 and a 52 week high of $129.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 2.75 and a current ratio of 3.33. The company has a market capitalization of $10.86 billion, a PE ratio of 39.66, a PEG ratio of 3.12 and a beta of 0.98. The company has a 50 day moving average price of $88.59 and a two-hundred day moving average price of $92.30.

Revvity (NYSE:RVTY) last issued its earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. During the same quarter in the prior year, the firm earned $1.22 earnings per share. The business’s quarterly revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity’s dividend payout ratio is presently 11.86%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Stifel Nicolaus cut their price objective on shares of Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Weiss Ratings lowered shares of Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, October 8th. Evercore ISI cut their price objective on shares of Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a report on Tuesday, October 7th. Barclays cut their price objective on shares of Revvity from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Thursday, October 2nd. Finally, Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Revvity currently has an average rating of “Moderate Buy” and an average price target of $116.62.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.